Shujing Li
Taiyuan, 030001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Multiplex Immune Profiling Reveals the Role of Serum Immune Proteomics in Predicting Response to Radioiodine after Total Resection of Papillary Thyroid Carcinoma.
Journal: Journal of proteome research
Published: December 05, 2025
Engineered hUCMSC-derived extracellular vesicles deliver circ-0000258 to restore p53-mediated tumor suppression in papillary thyroid carcinoma.
Journal: BMC cancer
Published: May 28, 2025
CALML6 as a potential diagnostic marker for thyroid cancer promotes thyroid cancer cell proliferation via modulating the immune microenvironment.
Journal: Gene
Published: July 25, 2024
Comprehensive Long-Read Sequencing Analysis Discloses the Transcriptome Features of Papillary Thyroid Microcarcinoma.
Journal: The Journal of clinical endocrinology and metabolism
Published: August 24, 2023
Genomic amplification of long noncoding RNA HOTAIRM1 drives anaplastic thyroid cancer progression via repressing miR-144 biogenesis.
Journal: RNA biology
Published: September 21, 2020
LINC00893 inhibits papillary thyroid cancer by suppressing AKT pathway via stabilizing PTEN.
Journal: Cancer biomarkers : section A of Disease markers
Published: September 14, 2020
Circular RNA EIF6 (Hsa_circ_0060060) sponges miR-144-3p to promote the cisplatin-resistance of human thyroid carcinoma cells by autophagy regulation.
Journal: Aging
Published: August 13, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026